TABLE 1.
Patient characteristics | No. patients in cohort (%) | No. patients in imaging subset (%) |
---|---|---|
Overall | 62 | 42 (67.75) |
Sex | ||
Male | 42 (67.74) | 30 (71.43) |
Female | 20 (32.26) | 12 (28.57) |
Age | ||
Mean±SD (range) | 62.47±11.26 (40.7–81.2) | 63.5±11.38 (40.7–81.2) |
Extent of surgery | ||
Biopsy | 6 (9.68) | 0 |
Subtotal resection | 40 (64.52) | 16 (38.10) |
Gross total resection (≥95%) | 16 (25.81) | 26 (61.90) |
Side | ||
Right | 29 (46.77) | 20 (47.62) |
Left | 30 (48.39) | 20 (47.62) |
Bilateral | 3 (4.84) | 2 (4.76) |
Location | ||
Frontal | 19 (30.65) | 12 (28.57) |
Occipital | 5 (8.06) | 3 (7.14) |
Temporal | 24 (38.71) | 18 (42.86) |
Parietal | 12 (19.35) | 8 (19.05) |
Thalamus | 2 (3.23) | 1 (2.38) |
Awake cortical mapping | ||
Yes | 11 (17.74) | 11 (26.19) |
No | 51 (82.26) | 31 (73.81) |
Chemotherapy treatment | ||
Yes | 44 (70.97) | 31 (73.81) |
No | 15 (24.19) | 8 (19.05) |
Unknown | 3 (4.84) | 3 (4.76) |
Radiotherapy treatment | ||
Yes | 50 (80.65) | 34 (80.95) |
No | 11 (17.74) | 7 (16.67) |
Unknown | 1 (1.61) | 1 (2.38) |
Progression-free survival in mo±SD (range) | 5.56±4.99 (0.56–24.3) | 5.84±5.50 (0.56–24.3) |
Overall survival in mo±SD (range) | 10.77±7.58 (0.07–32.65) | 11.26±7.87 (0.26–32.65) |